GRP
AXSM icon

Global Retirement Partners’s Axsome Therapeutics AXSM Stock Holding History

Global Retirement Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$78.5K Buy
430
+345
+406% +$48.2K ﹤0.01% 2060
2025
Q3 		$10.3K Hold
85
– – ﹤0.01% 2686
2025
Q2 		$8.87K Buy
+85
New +$9K ﹤0.01% 2662
2024
Q4 		$6.18K Sell
73
-24
-25% -$2.21K ﹤0.01% 2589
2024
Q3 		$8.72K Sell
97
-80
-45% -$6.98K ﹤0.01% 2345
2024
Q2 		$14.2K Buy
177
+154
+670% +$11.4K ﹤0.01% 2151
2024
Q1 		$1.83K Buy
23
+18
+360% +$1.51K ﹤0.01% 2779
2023
Q4 		$425 Buy
+5
New +$334 ﹤0.01% 3118

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Retirement Partners's AXSM Position: Q4 2025 in Review

Global Retirement Partners increased its Axsome Therapeutics (AXSM) stake by 406% in Q4 2025, buying an estimated $48.2K and bringing the position to 430 shares worth $78.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Global Retirement Partners first reported a position in AXSM in Q4 2023 and has held it in 8 quarters since. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

  • Global Retirement Partners held 430 shares of Axsome Therapeutics worth $78.5K as of Q4 2025.
  • Global Retirement Partners bought 345 Axsome Therapeutics shares in Q4 2025, an estimated $48.2K.
  • Axsome Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2060 holding.
  • Global Retirement Partners first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • 398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.